Biblio

Filters: Author is Ren, Yan [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E

Liu R, Jia W, Zou H, Wang X, Ren Y, Zhao J, Wang L, Li M, Qi Y, Shen Y, et al. Expression of CD44 and CD29 by PEComa cells suggests their possible origin of mesenchymal stem cells. Int J Clin Exp Pathol. 2015;8(10):13023-33.

M

Liu H, Deng S, Han L, Ren Y, Gu J, He L, Liu T, Yuan Z-X. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces. 2021;209(Pt 1):112163.

O

Kalff A, Khong T, Mithraprabhu S, Bergin K, Reynolds J, Bowen KM, Thakurta A, Guzman R, Wang M, Couto S, et al. Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Leuk Lymphoma. 2019:1-9.

R

Shi H, Fu Q, Li G, Ren Y, Hu S, Ni W, Guo F, Shi M, Meng L, Zhang H, et al. Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells. Cell Reprogram. 2015.